The action, which began with a petition from the Indian Medical Association, brings to light the threat posed by deceptive advertising, which persists even after the corporation has been warned about them in the past.
In November, the Supreme Court issued a warning to Patanjali, stating that if any misleading claims were made about the products’ ability to cure certain diseases, they would be subject to a punishment of Rs 1 crore per product.
Source: The Economic Times
Additionally, the court banned the company from promoting goods meant to cure particular ailments that were mentioned in the Drugs and Magic Remedies (Objectionable Advertisements) Act of 1954. The message is very clear: misleading advertising that aims to boost profits will not be accepted, particularly in the vital area of healthcare. Such actions are essential to halting the decline of public confidence.
The SC has issued a warning to the company not to disparage rival medical systems. The importance of strictly enforcing laws is underscored by the court’s valid concerns about the efficiency of relevant government agencies and regulatory bodies.
Source: Mint
The court’s request for clarification regarding the actions taken by the Centre in accordance with different laws could aid in highlighting any inconsistencies in the way that policies meant to maintain advertising standards are implemented.
The SC’s unwavering position upholds the idea that private interests shouldn’t take precedence over the general good and establishes a precedent for accountability in the health sector. People that engage in unethical behaviour are going to have to pay a price for their activities. It is hoped that the serial offenders will at last change their ways under close judicial examination.
What do you think about this? Comment below.
